Join Cooley FDA and legislative experts as they share FDA Enforcement trends in the life sciences space as well as discuss the recent legislative activity that life sciences companies should be aware. This panel will also discuss President Biden’s recent nomination of Dr. Robert Califf as the new FDA head and what that might mean for FDA policy and enforcement moving forward.
This webinar is part of our 2022 Life Sciences & Healthcare Innovation Program, Cooley’s 15th annual event in conjunction with the J.P. Morgan Healthcare Conference.
For more information, please email Rebecca Lanz.